The outcome of the 2024 U.S. presidential election, one of the most consequential in recent history, was determined in no small part by concerns about the cognitive state of President Biden and the ...
In fall 2024, xanomeline trospium chloride (XT) was approved by the U.S. Food and Drug Administration for the treatment of adults with schizophrenia. In an earlier post, we reviewed evidence that this ...
Social cognitive deficits are common and impact functional outcomes in people with schizophrenia spectrum disorders (SSDs). Functional brain networks during task and rest show complex relationships ...
Cognitive model suggests that social anxiety disorder (SAD) is maintained by persistent biases in attention, interpretation, and memory. Neuroscientific perspectives further implicate that ...